Tags |
|
|
Useful Advices - How to Handle the Price Objection
When your prospect asks you about the price of your product or ser
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
vice, what's important is not that you tell them, but rather what
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
happens next. Ask yourself, “What do you say after you give them
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
he price?" 80% of your competition either:
1) Remain silent, wa
1) Remain silent, wa
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
iting for them to ask another question
2) Keep pitching thei
2) Keep pitching thei
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
product or service.
3) Move onto another qualifying questio
3) Move onto another qualifying questio
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
n.
Guess what? All these responses are wrong. If you do any of
Guess what? All these responses are wrong. If you do any of
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
these, you're missing a golden opportunity to find out where your
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
rospect stands in regards to budget. The right question? Ask the
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
m how they feel or where they stand in regards to the price you ju
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
t gave them. Use any of these:
1) How does that price sound to
1) How does that price sound to
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
you?
2) Is that within your budget?
3) Which of those
2) Is that within your budget?
3) Which of those
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
price points appeal to you the most?
4) Is that what you are
4) Is that what you are
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
looking to spend?
Whenever your prospect asks about the price, an
Whenever your prospect asks about the price, an
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
d you give it, you deserve and must qualify on it. The top 20% au
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
omatically do and move that much closer to getting the information
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
they need to close the sale.
The other 80%? They miss this gold
The other 80%? They miss this gold
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
en opportunity because they don't qualify for it. From here on ou
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
, incorporate these price-qualifying questions and always, always
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
use them. You'll be amazed by your results.
Have a powerful week
Have a powerful week
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefuladvices.org.ua/article/39401/usefuladvices-How-to-Handle-the-Price-Objection.html">How to Handle the Price Objection</a>
BB link (for phorums):
[url=http://www.usefuladvices.org.ua/article/39401/usefuladvices-How-to-Handle-the-Price-Objection.html]How to Handle the Price Objection[/url]
Related Articles:
Radio Advertising: A Long History Of Excellence
Bookmark it:
|